She had a lead role in defining the CMC, regulatory and analytical strategies of a start-up gene therapy company with success taking an ocular AAV product to pivotal / Phase 3 trials, together with extensive experience supporting the technical development of various clinical and pre-clinic products in the ocular and CNS space. She provides expert advice to external industry forums and advisory boards to facilitate the advancement of ATMPs.
Our Team

Clare Blue
Senior CMC Translation Consultant
About Clare
Clare has over 16 years CMC industry experience in the development and manufacture of gene therapy / biologics products, from pre-clinical to commercial.
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.